Evidence map›Paper›PMID 35241145›Full record

Trial reportTrials2022

The effects of remifentanil-propofol combined with dexmedetomidine on cognitive dysfunction in elderly patients after ureteroscopic holmium laser lithotripsy: a double-blind randomized controlled trial.

Fangjun Wang, Dan Xie, Hongchun Xu, Qin Ye, Le Wu, Xiao Pei Gao

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Trials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 3 pooled it
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 3 syntheses or guidelines pooled it, 9 citations in OpenAlex.

  1. Antianxiety effects of dexmedetomidine: systematic review and meta-analysis.European archives of psychiatry and clinical neuroscience · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Retrospective study of ureteral stenosis after holmium laser lithotripsy.The Journal of international medical research · 2024
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Fangjun WangDepartment of Anesthesiology, Affiliated Hospital, North Sichuan Medical College, Nanchong, 637000, China. wfjlxy006@nsmc.edu.cn.
Dan XieDepartment of Anesthesiology, Affiliated Hospital, North Sichuan Medical College, Nanchong, 637000, China.
Hongchun XuDepartment of Anesthesiology, Affiliated Hospital, North Sichuan Medical College, Nanchong, 637000, China.
Qin YeDepartment of Anesthesiology, Affiliated Hospital, North Sichuan Medical College, Nanchong, 637000, China.
Le WuDepartment of Anesthesiology, Affiliated Hospital, North Sichuan Medical College, Nanchong, 637000, China.
Xiao Pei GaoDepartment of Anesthesiology, Affiliated Hospital, North Sichuan Medical College, Nanchong, 637000, China.
North Sichuan Medical University · CN

Funding

the Foundation of Si'chuan Health Department 17PJ215
6 · The paper itself

Abstract

backgroundA clinical study indicated that infusion of dexmedetomidine without a loading dose administered intraoperatively provided a smooth and hemodynamically stable emergence and improved the quality of recovery with fewer postoperative side effects and reduced analgesic requirements. The objective was to determine whether administering remifentanil-propofol combined with dexmedetomidine during general anesthesia would decrease the incidence and severity of postoperative emergence agitation, anxiety, and depression without affecting cognitive dysfunction in elderly patients.

methodsA total of 120 elderly patients scheduled for ureteroscopic holmium laser lithotripsy were randomly allocated to the PR group and administered normal saline, and the PRD group was administered dexmedetomidine 0.4 μg kg

resultsThe MMSE scores were lower at T

conclusionDexmedetomidine administration has no influence on postoperative cognitive dysfunction but could reduce both the dosage of remifentanil and propofol needed during ureteroscopic holmium laser lithotripsy and the incidence and severity of postoperative emergence agitation, anxiety, and depression in elderly patients.

trial registrationChinese Clinical Trial Registry ChiCTR1900021254 . Registered on 3 February 2019.

Indexed as

Cognitive DysfunctionDexmedetomidineLithotripsy, LaserPropofolAgedDouble-Blind MethodHolmiumHumansRemifentanilUreteroscopyDexmedetomidineHolmiumPropofolRemifentanilCognitive dysfunctionDexmedetomidineElderlyPropofolRemifentanil

Identifiers

PMID35241145
PMCPMC8895834
OpenAlexW4214810536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.